Intimation of Investor/Analyst Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has informed BSE that its management will hold a virtual group investor and analyst meeting on Wednesday, 25th March 2026 at 12:00 p.m. The disclosure is being made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The intimation is signed by Managing Director Fredun Nariman Medhora. No specific agenda, financial details, or material business information has been shared in this filing.
This is a routine regulatory disclosure about a scheduled investor interaction and is unlikely to have any direct impact on the stock price. Investors may watch for any post-meeting presentations or updates that could provide insights into the company's strategy or outlook.